ARRIVENT BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.1 USD | -0.25% |
|
+13.56% | 0.00% |
| May. 08 | ArriVent BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 30 | HC Wainwright Initiates ArriVent BioPharma With Buy Rating, $25 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 21.01 | 22.75 | 22.47 |
| Spread/Res. | -4.33% | -11.65% | -10.55% |
| Spread/Supp. | +11.73% | +31.37% | +30.18% |
| Support | 17.99 | 15.30 | 15.44 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AVBP Stock
- Charts ArriVent BioPharma, Inc.
